Psychemedics Corporation (PMD): Price and Financial Metrics


Psychemedics Corporation (PMD): $5.56

0.01 (+0.18%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PMD Stock Summary

  • PMD has a higher market value than merely 9.68% of US stocks; more precisely, its current market capitalization is $31,215,169.
  • With a year-over-year growth in debt of -30.47%, PSYCHEMEDICS CORP's debt growth rate surpasses just 10.43% of about US stocks.
  • Over the past twelve months, PMD has reported earnings growth of -2,478.26%, putting it ahead of only 0.59% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to PSYCHEMEDICS CORP are AMRN, NEO, DERM, BLBX, and CLIR.
  • Visit PMD's SEC page to see the company's official filings. To visit the company's web site, go to www.psychemedics.com.

PMD Valuation Summary

  • In comparison to the median Healthcare stock, PMD's price/sales ratio is 41.46% lower, now standing at 1.2.
  • Over the past 243 months, PMD's price/sales ratio has gone down 1.9.

Below are key valuation metrics over time for PMD.

Stock Date P/S P/B P/E EV/EBIT
PMD 2023-01-20 1.2 2.7 -15.6 -11.7
PMD 2023-01-19 1.2 2.6 -15.3 -11.5
PMD 2023-01-18 1.2 2.7 -15.8 -11.8
PMD 2023-01-17 1.2 2.6 -15.3 -11.4
PMD 2023-01-13 1.1 2.5 -14.6 -10.9
PMD 2023-01-12 1.2 2.6 -14.8 -11.1

PMD Growth Metrics

    The 3 year price growth rate now stands at -47.81%.
  • The 5 year net income to common stockholders growth rate now stands at -90.78%.
  • The year over year net income to common stockholders growth rate now stands at 80.4%.
Over the past 49 months, PMD's revenue has gone down $16,524,000.

The table below shows PMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 25.973 3.561 -2.017
2022-06-30 26.13 0.839 -1.181
2022-03-31 25.704 1.172 -0.709
2021-12-31 24.909 0.414 -0.665
2021-09-30 23.808 0.989 0.413
2021-06-30 22.309 -0.117 -1.433

PMD Stock Price Chart Interactive Chart >

Price chart for PMD

PMD Price/Volume Stats

Current price $5.56 52-week high $7.50
Prev. close $5.55 52-week low $4.85
Day low $5.51 Volume 3,700
Day high $5.62 Avg. volume 3,289
50-day MA $5.38 Dividend yield 5.04%
200-day MA $6.14 Market Cap 31.39M

Psychemedics Corporation (PMD) Company Bio


Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company’s tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. The company was founded in 1985 and is based in Acton, Massachusetts.


PMD Latest News Stream


Event/Time News Detail
Loading, please wait...

PMD Latest Social Stream


Loading social stream, please wait...

View Full PMD Social Stream

Latest PMD News From Around the Web

Below are the latest news stories about PSYCHEMEDICS CORP that investors may wish to consider to help them evaluate PMD as an investment opportunity.

Psychemedics Third Quarter 2022 Earnings: US$0.02 loss per share (vs US$0.13 profit in 3Q 2021)

Psychemedics ( NASDAQ:PMD ) Third Quarter 2022 Results Key Financial Results Revenue: US$6.52m (down 2.4% from 3Q...

Yahoo | November 12, 2022

Psychemedics Corporation Reports Third Quarter 2022 Financial Results and Declares Quarterly Cash Dividend

ACTON, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the third quarter ended September 30, 2022. The Company also announced a cash quarterly dividend of $0.07 per share payable to the shareholders of record as of December 2, 2022, to be paid on December 16, 2022.

GlobeNewswire | November 9, 2022

Psychemedics declares $0.07 dividend

Psychemedics (NASDAQ:PMD) declares $0.07/share quarterly dividend, in line with previous.Forward yield 4.45%Payable Dec. 16; for shareholders of record Dec. 2; ex-div Dec.

Seeking Alpha | November 9, 2022

One Psychemedics Corporation (NASDAQ:PMD) insider upped their stake by 13% in the previous year

From what we can see, insiders were net buyers in Psychemedics Corporation's ( NASDAQ:PMD ) during the past 12 months...

Yahoo | November 7, 2022

Don't Race Out To Buy Psychemedics Corporation (NASDAQ:PMD) Just Because It's Going Ex-Dividend

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Psychemedics...

Yahoo | August 18, 2022

Read More 'PMD' Stories Here

PMD Price Returns

1-mo 13.36%
3-mo -12.73%
6-mo -11.12%
1-year -19.56%
3-year -37.80%
5-year -67.21%
YTD 13.36%
2022 -27.73%
2021 38.90%
2020 -43.26%
2019 -38.19%
2018 -20.09%

PMD Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PMD Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9297 seconds.